KENNEDY CAPITAL MANAGEMENT LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 69 filers reported holding RECRO PHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
KENNEDY CAPITAL MANAGEMENT LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q2 2020$1,381,000
-63.4%
303,516
-34.3%
0.04%
-71.2%
Q1 2020$3,774,000
-52.0%
461,885
+7.6%
0.14%
-27.6%
Q4 2019$7,865,000
+62.8%
429,083
-1.6%
0.19%
+60.0%
Q3 2019$4,830,000
-5.1%
435,946
-12.8%
0.12%
-0.8%
Q2 2019$5,087,000
-27.4%
500,192
-58.2%
0.12%
+45.8%
Q1 2019$7,010,000
+97.2%
1,196,214
+138.9%
0.08%
-5.7%
Q4 2018$3,554,000
+103.1%
500,625
+103.4%
0.09%
+166.7%
Q3 2018$1,750,000
+40.7%
246,100
-0.7%
0.03%
+43.5%
Q2 2018$1,244,000247,8460.02%
Other shareholders
RECRO PHARMA INC shareholders Q4 2018
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders